Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00533871 · ClinicalTrials.gov registry record
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 61
- Enrollment target
NCT00533871: Completed study, sponsored by Ohio State University.
NCT00533871 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00533871 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Preeclampsia is a common disease state occurring in the third trimester of pregnancy, with an incidence of approximately 5-10% in the US. Hypertension (high blood pressure), a primary symptom of pre-eclampsia, may be present in women who were hypertensive prior to becoming pregnant.B-type (also known as brain) natriuretic peptide (BNP) is known to be made and released from the heart ventricles when the heart is strained. There is also evidence that BNP is secreted in the placenta, and may increase in preeclampsia and chronic hypertension in pregnancy.The purpose of the study is to determine if a maternal blood sample analyzed for the quantity of BNP is helpful in differentiating between pre-eclampsia and chronic high blood pressure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2003-02 |
| Est. Completion | 2005-06 |
What the finished NCT00533871 record still lists
NCT00533871 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00533871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00533871 about?
NCT00533871 is a clinical study titled "Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia". Preeclampsia is a common disease state occurring in the third trimester of pregnancy, with an incidence of approximately 5-10% in the US. Hypertension (high blood pressure), a primary symptom of pre-eclampsia, may be present in women who were hypertensive prior to becoming pregnant.B-type (also know...
What is the current status of trial NCT00533871?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2003-02. Estimated completion is 2005-06.
Who is sponsoring clinical trial NCT00533871?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia